Article
Evaluation and consequences of heterogeneity in the circulating tumor cell compartment.
Oncotarget - 26 Jul 2016
Brouwer Anja, De Laere Bram, Peeters Dieter, Peeters Marc, Salgado Roberto, Dirix Luc, Van Laere Steven
Abstract excerpt
A growing understanding of the molecular biology of cancer and the identification of specific aberrations driving cancer evolution have led to the development of various targeted agents. Therapeutic decisions concerning these drugs are often guided by single biopsies of the primary tumor. Yet, it is well known that tumors can exhibit significant heterogeneity and change over time as a result of selective...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
